Fig. 3
From: Unbiased assessment of 2-arachidonoylglycerol in cardiovascular inflammation
Expression of CRFs increases with disease progression of cardiac diseases. (A) Schema of blood sample acquisition and overview on patient groups undergoing cardiac catheterization. (B) Heatmap of Z-score transformed CRF concentrations in CAD and NSTEMI patients as well as control patients (non CAD). Samples were taken from the periphery (Sheath, Sh) or the cardiac aorta (CA). (C) Box-and-whisker plots for CRFs which increase with disease severity and maximum plasma concentrations in the CA. (D) Statistics for the correlation of CRFs with 2-AG levels in the sheath were calculated as Pearson’s correlation coefficients (r). (n = 9–42).
